KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Net Income towards Common Stockholders (2016 - 2025)

National Health Investors (NHI) has disclosed Net Income towards Common Stockholders for 14 consecutive years, with $38.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Income towards Common Stockholders fell 11.8% year-over-year to $38.1 million, compared with a TTM value of $142.0 million through Dec 2025, up 2.98%, and an annual FY2025 reading of $142.0 million, up 2.98% over the prior year.
  • Net Income towards Common Stockholders was $38.1 million for Q4 2025 at National Health Investors, up from $32.8 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $43.2 million in Q4 2024 and bottomed at $21.7 million in Q2 2022.
  • Average Net Income towards Common Stockholders over 4 years is $33.7 million, with a median of $34.3 million recorded in 2022.
  • Peak annual rise in Net Income towards Common Stockholders hit 83.45% in 2023, while the deepest fall reached 14.92% in 2023.
  • Year by year, Net Income towards Common Stockholders stood at $34.5 million in 2022, then dropped by 7.08% to $32.0 million in 2023, then surged by 34.93% to $43.2 million in 2024, then decreased by 11.8% to $38.1 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for NHI at $38.1 million in Q4 2025, $32.8 million in Q3 2025, and $36.9 million in Q2 2025.